The UK's biggest drug company, GlaxoSmithKline, saw profit before tax fall 12.5pc to £1.9bn for the first quarter of the year as it continued to struggle against reduced sales of its diabetes drug Avandia. Although outgoing chief executive Jean-Pierre Garnier said sales of the drug, which were hit by a health scare last year, had started to show some signs of recovery, he warned that the rebuilding process would take time.
GlaxoSmithKline suffers from poor sales of diabetes drug Avandia - The Telegraph 24th April 2008
Thursday, April 24, 2008
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment